Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matthew Stanton is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/07/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 08/07/2024 | CYRX | Buy Now | CryoPort | $5.34 | 49.67% | Matthew Stanton21% | $20 → $8 | Downgrade | Buy → Hold | Get Alert |
| 04/04/2024 | CYRX | Buy Now | CryoPort | $5.34 | 292.89% | Matthew Stanton21% | $17 → $21 | Assumes | → Buy | Get Alert |
| 04/04/2024 | LAB | Buy Now | Standard BioTools | $1.05 | 209.52% | Matthew Stanton21% | → $3.25 | Initiates | → Buy | Get Alert |
| 04/04/2024 | BLFS | Buy Now | BioLife Solns | $20.88 | 5.36% | Matthew Stanton21% | → $22 | Initiates | → Buy | Get Alert |
| 04/04/2024 | AZTA | Buy Now | Azenta | $30.38 | 110.66% | Matthew Stanton21% | → $64 | Initiates | → Hold | Get Alert |
